Chemical Medicine Research Institute mainly researches on the synthesis of brand-name drugs. Now there are over 50 employees, including 2 engineers, 4 doctors, and over 10 masters. The Institute is equipped with advanced facilities and the experimental conditions such as ultra-high temperature, ultra-low temperature, high pressure and hydrogenation. It is also equipped with imported precision analytical instruments such as Agilent-1260 HPLC for reaction control.

The Institute has established a long-term cooperation system with scientific research institutes and universities such as School of Medicine of Tsinghua University and China Pharmaceutical University, and maintained the industry-university-research cooperation.

There are over 40 projects in research, in which there are 3 class-A new medicines and class-C new medicines account for 70%. In recent years, the Institute has been granted with the approval for the exclusive new medicine categories such as Dizocine. The sales of Dizocine BPC are over 200,000,000 Yuan. It not only benefits a lot of patients but vigorously propels the development of YRPG.